Digital Health · Pancreatic Disease

Building the infrastructure
pancreatic disease patients
have never had.

PancreaTrack MedTech LLC is a digital health company creating disease-specific technology for patients living with chronic pancreatitis, exocrine pancreatic insufficiency, and post-TPIAT conditions — and the physicians who care for them.

Ohio LLC — Entity #5613813 AWS BAA Executed USPTO Trademark Pending
Visit PancreaTrack AI Investor Inquiries
PancreaTrack MedTech

Who We Are

Founded from lived experience. Built for patients.

PancreaTrack MedTech LLC was founded by a chronic pancreatitis patient whose TPIAT surgery was aborted after seven hours on the operating table. What came next was a firsthand understanding of what patients in this community lack — structured tools, clinical data continuity, and a platform built specifically for their disease.

PancreaTrack MedTech is not a wellness company. Every feature we build reflects the clinical reality of chronic pancreatic disease — from PERT enzyme optimization to verified physician data sharing.

PancreaTrack MedTech LLC · Louisville, OH · Founded 2026
~275K
Americans with\nchronic pancreatitis
~500K
Estimated EPI\npatients, most undiagnosed
4–5 yrs
Average delay to\nEPI diagnosis
$0
Disease-specific platforms\nbefore PancreaTrack

Our Product

PancreaTrack AI — Live and in production

The first disease-specific digital health platform built exclusively for pancreatitis patients and their physicians.

PancreaTrack AI
Live · In Production

PancreaTrack AI

A web-based platform connecting chronic pancreatitis patients with their physicians through structured health data, AI-powered insights, and a verified clinical portal.

Daily pain logging with severity, location, and trigger tracking
Meal and macro tracking with USDA FoodData Central integration
PERT enzyme optimizer — correlates lipase dosing against fat intake and outcomes
AI meal photo analysis powered by Google Gemini 2.5 Vision
AI Trigger Finder — 90-day dietary trigger identification
Physician-ready pre-appointment summaries generated by Gemini Pro
NPI-verified physician portal with AI patient briefs and care note threading
Document Q&A — patients upload labs and imaging for plain-language explanation
pancreatrack.com Physician Portal

The Opportunity

A massive, underserved patient community with no digital infrastructure

~$3.6B
Annual US healthcare costs attributed to pancreatitis admissions
~20%
30-day hospital readmission rate following acute pancreatitis discharge
80%
Of chronic pancreatitis patients develop exocrine pancreatic insufficiency
40%
Of chronic pancreatitis patients develop type 3c diabetes mellitus
0
Commercially available platforms purpose-built for pancreatitis before PancreaTrack
$188B
Projected global digital health market by 2026 (Grand View Research)

For Investors

Seed stage. Working product. Real patients. Real physicians.

PancreaTrack AI is live and in production with an active patient base, a functioning NPI-verified physician portal, and a full AI feature suite. We are raising a seed round to accelerate growth and expand clinical partnerships.

$9/mo
Pro subscription price — exceptionally sticky in chronic disease cohorts
$108
Annual revenue per Pro subscriber
18–25%
Expected free-to-paid conversion with AI-gated features
~$8–15M
Pre-money seed valuation range based on SaaS comparables
Defensible Moat
Disease specificity creates a moat no general health app can replicate without full re-architecture. PERT optimization alone has no known equivalent.
Physician Flywheel
Free physician portal creates a B2C-through-B2B referral engine. One gastroenterologist with 200 pancreatitis patients is a direct pipeline of 200 potential subscribers.
Research Asset
At scale, PancreaTrack's longitudinal dataset — PERT dosing, dietary triggers, pain patterns — represents a research asset with no equivalent in published literature.

Get in Touch

Let's talk

Whether you're a clinician, researcher, potential partner, or investor — we'd love to hear from you.

Tim Lunsford
Founder, PancreaTrack MedTech LLC
General & Founder
tim.lunsford@pancreatrack.com
Partnerships & Clinical
partnerships@pancreatrack.com
Research Inquiries
research@pancreatrack.com
Investor Relations
investors@pancreatrack.com
Platform
pancreatrack.com